According to studies, the level of Copper tripeptide-1 (GHK-Cu) decreases with age due to a combination of lower production, faster degradation, and increased consumption during continuous repair processes. Research indicates that plasma levels drop from approximately 200 ng/mL at age 20 to around 80 ng/mL by age 60. This gradual decline suggests a distinct, age-related reduction in the availability of this peptide.
At a molecular level, one of the primary factors is enzymatic degradation. GHK is susceptible to breakdown by enzymes such as carboxypeptidases, which are responsible for breaking down small peptides into smaller fragments. Over time, continuous enzymatic activity reduces both the stability and circulating levels of GHK. Consequently, it becomes more difficult for the body to maintain consistent levels, particularly in tissues requiring continuous repair, such as ageing skin or chronic wounds.
Another significant cause is increased consumption during repair processes and stress responses. GHK is released from extracellular matrix structural proteins, including collagen and SPARC, especially in situations of tissue damage or remodelling. Once released, it acts as a signalling molecule that activates repair processes. These include collagen production, new blood vessel formation (angiogenesis), nerve growth, and immune cell recruitment. As the body ages, more damage accumulates and regenerative processes slow down. This increases the demand for repair signals, meaning that available GHK is utilised more often and is not fully replenished.
Additionally, the natural decline in regenerative capabilities is significant. In younger individuals, repair systems function more effectively, and GHK levels remain higher, supporting processes such as fibroblast activity, stem cell function, and extracellular matrix renewal. With age, fibroblasts become less active, stem cell activity declines, and overall tissue renewal slows down. This leads to a reduced production and less efficient recycling of GHK in the body.
Changes in gene expression and cell signalling may also be significant. GHK is known to affect many genes related to repair, antioxidant protection and the control of inflammation. As the body ages, changes occur in gene activity, which can lead to a weakening of the pathways responsible for maintaining GHK levels – both through its production, release and stability – which further contributes to its decline.
The effects of a reduced level of Copper tripeptide-1 (GHK-Cu) are linked to decreased support for the body's essential maintenance processes. This includes reduced collagen and elastin production, decreased new blood vessel formation, weaker antioxidant protection, and increased inflammatory activity. Collectively, these changes reflect a shift towards slower regeneration and greater accumulation of cellular damage over time.
It should be emphasized that these observations are based on biochemical, cellular, and preclinical studies. They describe patterns associated with ageing but do not confirm direct clinical interventions or effects in humans.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018 Jul 7;19(7):1987. doi: 10.3390/ijms19071987. PMID: 29986520; PMCID: PMC6073405. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
- Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020 Mar 27;2(1):58-61. doi: 10.31491/apt.2020.03.014. PMID: 35083444; PMCID: PMC8789089. https://pmc.ncbi.nlm.nih.gov/articles/PMC8789089/
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi: 10.1155/2015/648108. Published 2015 Jul 7. PMID: 26236730; PMCID: PMC4508379. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/